focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,797.50
Bid: 1,797.50
Ask: 1,798.50
Change: -15.00 (-0.83%)
Spread: 1.00 (0.056%)
Open: 1,792.50
High: 1,802.00
Low: 1,792.50
Prev. Close: 1,812.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK BROKER RATINGS: Goldman Cuts Antofagasta, Raises Anglo American

Fri, 23rd Jan 2015 09:52

LONDON (Alliance News) - The following UK shares received analyst recommendations Friday morning and Thursday afternoon:
----------
FTSE 100
----------
SOCGEN RAISES REED ELSEVIER PRICE TARGET TO 1275 (1105) PENCE - 'BUY'
----------
SOCGEN RAISES WPP PRICE TARGET TO 1685 (1530) PENCE - 'BUY'
----------
SOCGEN RAISES PEARSON PRICE TARGET TO 1220 (1105) PENCE - 'HOLD'
----------
SOCGEN RAISES ITV PRICE TARGET TO 240 (220) PENCE - 'HOLD'
----------
SOCGEN RAISES SKY PLC PRICE TARGET TO 1110 (1045) PENCE - 'BUY'
----------
BERENBERG CUTS CENTRICA PRICE TARGET TO 300 (370) PENCE - 'BUY'
----------
BERNSTEIN CUTS HSBC PRICE TARGET TO 660 (800) PENCE - 'OUTPERFORM'
----------
BERENBERG RAISES ASTRAZENECA PRICE TARGET TO 4800 (4240) PENCE - 'HOLD'
----------
BERENBERG RAISES GLAXOSMITHKLINE PRICE TARGET TO 1620 (1540) PENCE - 'HOLD'
----------
BERENBERG CUTS INTERTEK PRICE TARGET TO 2375 (2800) PENCE - 'HOLD'
----------
BARCLAYS RAISES ST JAMES'S PLACE PRICE TARGET TO 939 (916) PENCE - 'OVERWEIGHT'
----------
TRADERS: GOLDMAN CUTS ANTOFAGASTA TO 'NEUTRAL' ('BUY')
----------
JPMORGAN CUTS ANTOFAGASTA PRICE TARGET TO 710 (755) PENCE - 'NEUTRAL'
----------
TRADERS: GOLDMAN RAISES ANGLO AMERICAN TO 'NEUTRAL' ('SELL')
----------
JPMORGAN CUTS ANGLO AMERICAN PRICE TARGET TO 1120 (1340) PENCE - 'UNDERWEIGHT'
----------
UBS CUTS EXPERIAN TO 'NEUTRAL' ('BUY')
----------
CITIGROUP RAISES ST JAMES'S PLACE PRICE TARGET TO 1000 (870) PENCE - 'BUY'
----------
NUMIS RAISES ST JAMES'S PLACE PRICE TARGET TO 980 (850) PENCE - 'ADD'
----------
CITIGROUP CUTS WEIR GROUP PRICE TARGET TO 1750 (1900) PENCE - 'NEUTRAL'
----------
MORGAN STANLEY RAISES IAG PRICE TARGET TO 7.50 (6.60) EUR - 'OVERWEIGHT'
----------
NUMIS RAISES WHITBREAD PRICE TARGET TO 5600 (5150) PENCE - 'ADD'
----------
JPMORGAN RAISES WHITBREAD PRICE TARGET TO 5250 (5000) PENCE - 'OVERWEIGHT'
----------
JPMORGAN RAISES COMPASS GROUP PRICE TARGET TO 1150 (1050) PENCE - 'NEUTRAL'
----------
JPMORGAN RAISES FRESNILLO PRICE TARGET TO 1190 (1110) PENCE - 'OVERWEIGHT'
----------
JPMORGAN RAISES INTERCONTINENTAL HOTELS TARGET TO 2600 (2200) PENCE - 'NEUTRAL'
----------
JPMORGAN RAISES WHITBREAD PRICE TARGET TO 5250 (5000) PENCE - 'OVERWEIGHT'
----------
JPMORGAN CUTS BHP BILLITON PRICE TARGET TO 1550 (1870) PENCE - 'NEUTRAL'
----------
JPMORGAN CUTS RIO TINTO PRICE TARGET TO 3400 (3500) PENCE - 'OVERWEIGHT'
----------
FTSE 250
----------
JPMORGAN RAISES BETFAIR PRICE TARGET TO 1600 (1510) PENCE - 'OVERWEIGHT'
----------
NUMIS RAISES BALFOUR BEATTY TO 'ADD' ('HOLD') - TARGET 230 PENCE
----------
SOCGEN RAISES INFORMA TO 'BUY' ('HOLD') - TARGET 585 (500) PENCE
----------
UBS CUTS OXFORD INSTRUMENTS PRICE TARGET TO 950 (1300) PENCE - 'BUY'
----------
BERENBERG CUTS OXFORD INSTRUMENTS TO 'HOLD' ('BUY') - TARGET 950 (1360) PENCE

BARCLAYS CUTS OXFORD INSTRUMENTS PRICE TARGET TO 860 (1140) PENCE - 'EQUALWEIGHT'

JPMORGAN CUTS OXFORD INSTRUMENTS TARGET TO 1200 (1350) PENCE - 'OVERWEIGHT'

UBS CUTS RENTOKIL INITIAL TO 'SELL' ('NEUTRAL') - TARGET 112 PENCE
----------
UBS CUTS OPHIR ENERGY PRICE TARGET TO 150 (230) PENCE - 'NEUTRAL'
----------
BARCLAYS CUTS ELECTROCOMPONENTS PRICE TARGET TO 210 (229) PENCE - 'EQUALWEIGHT'
----------
BARCLAYS CUTS PREMIER FARNELL PRICE TARGET TO 188 (205) PENCE - 'EQUAL WEIGHT'
----------
TRADERS: JPMORGAN CUTS TELECITY GROUP TO 'NEUTRAL' ('OVERWEIGHT')
----------
TRADERS: MORGAN STANLEY CUTS MICHAEL PAGE TO 'EQUAL-WEIGHT' ('OVERWEIGHT')
----------
UBS CUTS MICHAEL PAGE TO 'NEUTRAL' ('BUY')
----------
EXANE BNP CUTS CRODA TO 'NEUTRAL' ('OUTPERFORM') - TARGET 2770 (2820) PENCE
----------
EXANE BNP CUTS ELEMENTIS TO 'NEUTRAL' ('OUTPERFORM') - TARGET 300 PENCE
----------
CITIGROUP RAISES HENDERSON GROUP PLC PRICE TARGET TO 246 (218) PENCE - 'BUY'
----------
MORGAN STANLEY RAISES HAYS PRICE TARGET TO 165 (160) PENCE - 'OVERWEIGHT'
----------
JPMORGAN CUTS TELECITY TO 'NEUTRAL' ('OVERWEIGHT') - TARGET 900 (925) PENCE
----------
JPMORGAN RAISES LADBROKES PRICE TARGET TO 110 (95) PENCE - 'UNDERWEIGHT'
----------
JPMORGAN RAISES PLAYTECH PRICE TARGET TO 635 (615) PENCE - 'NEUTRAL'
----------
JPMORGAN RAISES SSP GROUP PRICE TARGET TO 320 (310) PENCE - 'OVERWEIGHT'
----------
JPMORGAN CUTS KAZ MINERALS PRICE TARGET TO 335 (365) PENCE - 'OVERWEIGHT'
----------
JPMORGAN CUTS VEDANTA PRICE TARGET TO 530 (960) PENCE - 'NEUTRAL'
----------
MAIN MARKET AND AIM
----------
SOCGEN CUTS DAILY MAIL PRICE TARGET TO 720 (740) PENCE - 'SELL'
----------
JPMORGAN RAISES GEM DIAMONDS PRICE TARGET TO 290 (280) PENCE - 'OVERWEIGHT'
----------
JPMORGAN RAISES HOCHSCHILD MINING PRICE TARGET TO 130 (125) PENCE - 'NEUTRAL'
----------
JPMORGAN CUTS FERREXPO PRICE TARGET TO 80 (110) PENCE - 'NEUTRAL'
----------
JPMORGAN CUTS PETROPAVLOVSK PRICE TARGET TO 9 (10) PENCE - 'UNDERWEIGHT'
----------
By Arvind Bhunjun; arvindbhunjun@alliancenews.com; @ArvindBhunjun

Copyright 2015 Alliance News Limited. All Rights Reserved.

More News
22 Jan 2024 17:08

Fate of most remaining Zantac lawsuits weighed by Delaware judge

Jan 22 (Reuters) - GSK, Pfizer and other pharmaceutical companies will urge a judge in Delaware this week to find that evidence plaintiffs' lawyers want to use in about 72,000 lawsuits claiming that the discontinued heartburn drug Zantac caused cancer is not supported by science.

Read more
22 Jan 2024 09:34

IN BRIEF: Oxford Nanopore appoints Keher to CFO as Cowper becomes COO

Oxford Nanopore Technologies - Oxford, England-based company specialising in nanopore DNA-sequencing - Appoints Nick Keher as chief financial officer and director, effective immediately. Keher will replace Tim Cowper as he moves into a new role as Oxford Nanopore's chief operating officer. The company says that Cowper has been performing the majority of COO duties for the past five years, and that he will lead the company's efforts to expand its international footprint. The company also says that new CFO Keher possesses "significant experience of financial leadership of complex, scientific businesses", having served in similar roles at Clinigen Group PLC, BenevolentAI SA, Royal Bank of Canada, Investec PLC and GSK PLC.

Read more
17 Jan 2024 09:38

UPDATE: GSK raises GBP978 million as cuts stake in Haleon to 4.2%

(Alliance News) - GSK PLC early Wednesday confirmed it agreed to sell 300 million shares in Haleon PLC, reducing its remaining stake in the consumer healthcare products spin-off to just 4.2%.

Read more
17 Jan 2024 08:05

GSK raises £978m through Haleon share sale

(Sharecast News) - GSK said on Wednesday that it has raised around £978m from the sale of shares in Haleon.

Read more
17 Jan 2024 07:46

LONDON BRIEFING: UK inflation surprises as unexpectedly rises to 4.0%

(Alliance News) - Stocks in London are called to open lower on Wednesday, following some hotter-than-expected consumer price data from the UK.

Read more
17 Jan 2024 07:31

GSK raises $1.24 bln from latest Haleon stake sale

Jan 17 (Reuters) - GSK has raised 978 million pounds ($1.24 billion) from a discounted sale of a stake in its spun-off consumer healthcare business Haleon, the British drugmaker said on Wednesday.

Read more
16 Jan 2024 17:04

GSK to sell GBP1 billion worth of Haleon shares as trims stake again

(Alliance News) - GSK PLC on Tuesday said it intends to sell around GBP1.00 billion worth of shares in Haleon PLC, as it continues to reduce its shareholding in the Weybridge, Surrey-based consumer healthcare spin-off.

Read more
16 Jan 2024 09:14

LONDON BROKER RATINGS: UBS raises GSK and cuts AstraZeneca

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
16 Jan 2024 08:15

UBS downgrades AstraZeneca to 'sell'

(Sharecast News) - UBS has downgraded AstraZeneca and upgraded rival GSK as part of its latest review of the European pharmaceutical sector.

Read more
16 Jan 2024 07:37

LONDON BRIEFING: UK jobless rate sticks at 4.2% but pay growth slows

(Alliance News) - Stocks in London are called to open lower on Tuesday, following data showing that the UK jobless rate was unchanged at 4.2% as pay growth slowed.

Read more
15 Jan 2024 08:42

Zantac fallout unfairly weighing on GSK, says Shore Capital

(Sharecast News) - Shore Capital has raised its target price and maintained a positive stance on biopharma giant GSK, saying that worries about the potential cost of Zantac litigation are unfairly weighing on the stock.

Read more
10 Jan 2024 09:35

LONDON BROKER RATINGS: BofA cuts Ashtead; UBS likes 3i Group

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
10 Jan 2024 08:25

GSK says Nucala gets green light in China for asthma treatment

(Alliance News) - GSK PLC on Wednesday said Nucala has been approved in China for the treatment of severe asthma.

Read more
10 Jan 2024 07:22

GSK's Nucala gets fresh approval in China

(Sharecast News) - GSK announced on Wednesday that the China National Medical Products Administration (NMPA) has granted approval for 'Nucala', or mepolizumab, as an add-on maintenance treatment for severe eosinophilic asthma in adults and adolescents aged 12 years and older.

Read more
9 Jan 2024 16:22

London close: Stocks finish red after choppy session

(Sharecast News) - London stocks had turned back into the red by the close on Tuesday, with recruitment firms and asset managers pacing the declines after some disappointing corporate updates.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.